Tri-Institutional PhD Program in Chemical Biology
化学生物学三机构博士项目
基本信息
- 批准号:9098769
- 负责人:
- 金额:$ 13.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Tri-Institutional PhD Program in Chemical Biology (TPCB) The Tri-Institutional PhD Program in Chemical Biology (TPCB) is an innovative graduate program that provides students with comprehensive training at the interface of chemistry, biology, and medicine. TPCB is unique in that it is offered jointly by three premier research institutions with adjoining campuses in the heart of New York City: Weill Cornell Medical College, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. This stand-alone, direct admission graduate program was established in 2001 as one of the first in the nation to focus specifically on training the next generation of chemical biology researchers. Over the last 14 years, TPCB has established itself as a leading graduate program in chemical biology, with 51 PhD graduates and 32 current students. The program includes students from both chemical and biological undergraduate backgrounds and combines quantitative chemical training with deep insights into forefront problems in biomedical research. The curriculum includes two chemical biology courses created specifically for TPCB students, additional core and elective courses, laboratory rotations, a Tri-Institutional Chemical Biology Seminar Series and journal club, a student Research-in-Progress seminar series, and an annual student-organized Tri-Institutional Chemical Biology Symposium. Students also receive extensive career development training and support as well as formal instruction in the Responsible Conduct of Research. TPCB students have exciting opportunities to conduct PhD thesis research with 46 outstanding faculty working across the spectrum of chemical biology and supported with over $45M in annual research funding. Students move seamlessly between the three institutions and have access to the state-of-the-art research facilities and rich scientific environment on all thre campuses, providing diverse opportunities to pursue both fundamental and translational research projects and to engage in multidisciplinary collaborations. Importantly, TPCB students are deeply involved in the organization and design of the training experience, and the program has evolved continually in response to student feedback. As a result, TPCB students have been exceptionally productive, publishing nearly 300 scientific papers at an average of 5.1 per PhD graduate. Our alumni have continued onto successful careers in academic institutions, pharmaceutical companies, biotechnology startups, and government labs. Our students come from a wide range of scientific and cultural backgrounds and this diversity is highly valued. The program welcomes students from underrepresented minority groups, those with disabilities, and those from disadvantaged socioeconomic backgrounds and works with each student individually to ensure that they have all of the resources necessary to thrive. TPCB receives strong institutional support but is still unable to admit all of the qualified candidates who apply. Thus,
this NIH NIGMS Chemistry-Biology Interface T32 training grant will enable further growth and enhancement of the student training experience in this highly successful program.
描述(由申请人提供): 化学生物学三机构博士项目 (TPCB) 化学生物学三机构博士项目 (TPCB) 是一个创新的研究生项目,为学生提供化学、生物学和化学领域的全面培训。 TPCB 的独特之处在于它由三个位于纽约市中心毗邻校区的顶级研究机构联合提供:威尔康奈尔医学院、洛克菲勒大学和纪念斯隆凯特琳癌症中心。这个独立的、直接录取的研究生项目成立于 2001 年,是美国第一个专门致力于培养下一代化学生物学研究人员的项目之一。在过去的 14 年里,TPCB 已成为该领域领先的研究生项目。该项目拥有 51 名博士毕业生和 32 名在读学生,其中包括化学和生物学本科背景的学生,并将定量化学培训与对生物医学研究前沿问题的深入见解相结合。该课程包括两门专门为 TPCB 学生创建的化学生物学课程。 ,额外的核心和选修课程、实验室轮换、三机构化学生物学研讨会系列和期刊俱乐部、学生正在进行的研究研讨会系列以及学生组织的年度三机构化学生物学研讨会学生还获得广泛的职业发展。 TPCB 的培训和支持以及负责任的研究行为的正式指导让学生有机会与 46 名化学生物学领域的杰出教师一起进行博士论文研究,并获得超过 4500 万美元的年度研究支持。学生在三个机构之间无缝流动,可以使用三个校区最先进的研究设施和丰富的科学环境,为开展基础和转化研究项目以及参与多学科合作提供了多样化的机会。重要的是,TPCB 学生深入参与培训体验的组织和设计,并且该计划根据学生的反馈不断发展。因此,TPCB 学生的生产力非常高,平均发表了近 300 篇科学论文。我们的校友在学术机构、制药公司、生物技术初创公司和政府实验室继续取得成功,他们来自广泛的科学和文化背景,这种多样性受到重视。 TPCB 与少数群体、残疾人和社会经济背景不利的学生单独合作,确保他们拥有茁壮成长所需的所有资源,但仍无法录取所有申请的合格候选人。 。因此,
NIH NIGMS 化学-生物接口 T32 培训补助金将进一步发展和增强这个非常成功的项目中的学生培训经验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEREK S TAN其他文献
DEREK S TAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEREK S TAN', 18)}}的其他基金
Tri-Institutional PhD Program in Chemical Biology
化学生物学三机构博士项目
- 批准号:
10618939 - 财政年份:2020
- 资助金额:
$ 13.81万 - 项目类别:
Tri-Institutional PhD Program in Chemical Biology
化学生物学三机构博士项目
- 批准号:
10414800 - 财政年份:2020
- 资助金额:
$ 13.81万 - 项目类别:
Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria
革兰氏阴性细菌中小分子积累的预测模型
- 批准号:
10226047 - 财政年份:2018
- 资助金额:
$ 13.81万 - 项目类别:
Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria
革兰氏阴性细菌中小分子积累的预测模型
- 批准号:
10460988 - 财政年份:2018
- 资助金额:
$ 13.81万 - 项目类别:
Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria
革兰氏阴性细菌中小分子积累的预测模型
- 批准号:
9761970 - 财政年份:2018
- 资助金额:
$ 13.81万 - 项目类别:
Predictive Models for Small-Molecule Accumulation in Gram-Negative Bacteria
革兰氏阴性细菌中小分子积累的预测模型
- 批准号:
9982190 - 财政年份:2018
- 资助金额:
$ 13.81万 - 项目类别:
Tri-Institutional PhD Program in Chemical Biology
化学生物学三机构博士项目
- 批准号:
9306134 - 财政年份:2015
- 资助金额:
$ 13.81万 - 项目类别:
Tri-Institutional PhD Program in Chemical Biology
化学生物学三机构博士项目
- 批准号:
8935325 - 财政年份:2015
- 资助金额:
$ 13.81万 - 项目类别:
Rational Design of Adenylation Enzyme Inhibitors
腺苷酸化酶抑制剂的合理设计
- 批准号:
8675862 - 财政年份:2012
- 资助金额:
$ 13.81万 - 项目类别:
Small Molecule Inhibitors of P. aeruginosa Quinolone (Pqs) Quorum Sensing
铜绿假单胞菌喹诺酮 (Pqs) 群体感应的小分子抑制剂
- 批准号:
8268842 - 财政年份:2012
- 资助金额:
$ 13.81万 - 项目类别:
相似国自然基金
信息化学物质介导“外来入侵种松树蜂-樟子松-网隙裂粉韧革菌”系统互作机制及分子基础
- 批准号:32371889
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于多维化学物质组的“淡豆豉打鲜生地”炮制机理研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于体内外化学物质和药效变化的相关性探讨黄精酒蒸增效机理
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多维化学物质组关联网络的养心氏片抗阿霉素心脏毒性药效物质及作用机制研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
长期不同施肥处理下红壤性水稻土有机质的化学物质组学特征演变
- 批准号:
- 批准年份:2020
- 资助金额:57 万元
- 项目类别:面上项目
相似海外基金
Sensory Mechanisms of Cadmium-Induced Behavioral Disorders Across Generations
镉引起的几代人行为障碍的感觉机制
- 批准号:
10747559 - 财政年份:2023
- 资助金额:
$ 13.81万 - 项目类别:
Investigating tRNA biology as a prognostic and oncogenic feature in pancreatic adenocarcinoma
研究 tRNA 生物学作为胰腺腺癌的预后和致癌特征
- 批准号:
10749469 - 财政年份:2023
- 资助金额:
$ 13.81万 - 项目类别:
Virginia Commonwealth University Maximizing Access to Research Careers (VCU MARC)
弗吉尼亚联邦大学最大限度地获得研究职业机会 (VCU MARC)
- 批准号:
10629576 - 财政年份:2023
- 资助金额:
$ 13.81万 - 项目类别:
Menopausal Knee-ds: Elucidating mechanisms and treatments for knee osteoarthritis
更年期膝关节:阐明膝骨关节炎的机制和治疗方法
- 批准号:
10749297 - 财政年份:2023
- 资助金额:
$ 13.81万 - 项目类别: